National Academies Press: OpenBook

HIV Screening of Pregnant Women and Newborns (1991)

Chapter: Appendix C: Cost Estimates: Early Intervention for HIV Infection

« Previous: Appndix B: Cost and Probability Assumptions Used in Cost-Effectiveness Analysis of Prenatal HIV Screening
Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×

APPENDIX C
COST ESTIMATES: EARLY INTERVENTION FOR HIV INFECTION

The following tables offer crude estimates of HIV screening program costs. Part 1 provides estimates of the costs per intervention, which include counseling, testing, and partner notification (Table C-1) and subsequent medical surveillance, prophylaxis, and treatment (Table C-2). Part 2 (Tables C-3 and C-4) includes cost estimates for a program. Table C-3 provides estimates of the counseling, testing, and partner notification costs per 1,000 HIV-positive individuals identified and, using the state of New Jersey as an example, estimates of total counseling and testing costs if all HIV-infected individuals in the state were identified. Table C-4 presents rough estimates of the costs of medical surveillance, prophylaxis, and treatment per 1,000 HIV-positive individuals identified across four different treatment categories (based on CD4+ cell counts). Also using New Jersey as an example, it provides estimates of the costs of early medical intervention for all HIV-infected individuals in the state.

These tables are by no means comprehensive, nor do they provide definitive cost estimates. State policymakers may find the cost estimates per 1,000 HIV-positive individuals (see Tables C-3a and C-4a) helpful in calculating the potential costs of a screening program for their state. They can estimate the number of HIV-infected childbearing women in their state and apply the cost figures per 1,000 HIV-positive individuals to arrive at an approximation of prenatal screening program costs.

Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×

Part 1: Cost Estimates Per Intervention

Counseling and Testing

Cost estimates for counseling and testing are provided by the Centers for Disease Control (March 1990). Estimates for the costs associated with HIV testing and counseling were prepared by the Division of Sexually Transmitted Diseases, based on a survey of approximately 15 states providing these services. The estimates include personnel fringe benefits and current overhead rates. Laboratory cost estimates were prepared by the Public Health Practice Program Office, based on a routinely conducted CDC survey of state health department laboratories and selected private laboratories.

Table C-1 Cost Estimates Per Intervention: Counseling and Testing

Item

HIV (-)

HIV (+)

Assumptions

LABORATORY

Kit (ELISA)

S1.75 (1x)

$ 5.25 (3x)

 

Lab time

0.43

1.28

$21,428 average lab tech annual salary; 50,400 tests/year

Personnel fringe benefits

0.11

0.33

25.5%

Overhead

1.15

3.43

50% of labor and kits

Subtotal

3.44

10.29

 

Kit (Western Blot)

 

20.00

 

Lab time

 

2.48

8,640 tests/year

Personnel fringe benefits

 

0.63

 

Overhead

 

11.56

 

Subtotal

 

34.67

 

COUNSELING

Pretest: 15 minutes counseling plus 15 minutes preparation and processing

Counselor

$ 6.78

$ 6.78

$26,029 (average annual salary)

Supervisor

1.36

1.36

$31,229 (average annual salary)

Clerical

0.78

0.78

$17,986 (average annual salary)

Personnel fringe benefits

2.27

2.27

25.5%

Overhead

4.48

4.48

40% of personnel

Subtotal

15.67

15.67

 

Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×

Item

HIV (-)

HIV (+)

Assumptions

Posttest: HIV (-): 30 minutes counseling plus 15 minutes processing HIV (+): 90 minutes counseling plus 15 minutes processing

Time

15.67 (30 min.)

47.01 (90 min.)

 

 

7.84 (15 min.)

7.84 (15 min.)

 

Total

42.62

115.48

 

PARTNER NOTIFICATION

Time

1 Partner Notified

 

$ 24.41

2 hrs., $23,430 (average annual salary for disease intervention specialist)

Personnel fringe benefits

 

6.22

 

Overhead

 

12.25

40% of personnel

Subtotal

 

42.88

 

Total

 

158.36

 

Medical Surveillance, Prophylaxis, and Treatment

Cost estimates are given for four treatment categories of asymptomatic HIV infection:

1 CD4+ cells > 500

Medical monitoring

2 CD4+ cells 200-500

Treatment with zidovudine

3 CD4+ cells < 200

Treatment with zidovudine, prophylaxis with trimethoprim-sulfamethoxazole

4 CD4+ cells < 200

Treatment with zidovudine, prophylaxis with aerosolized pentamidine

Three sources of cost estimates were used:

  1. P. S. Arno, D. Shenson, N. F. Siegel, P. Franks, and P. R. Lee, "Economic and Policy Implications of Early Intervention in HIV Disease," Journal of the American Medical Association 262(1989):1493-1498. The authors distinguish two treatment categories for purposes of cost estimation: 1 (CD4+ cells > 500), and 2-4 (CD4+ cells < 500).

Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×

The cost estimates reproduced in Table C-2 are mid-range figures from this paper.

  1. New Jersey Department of Health (NJ DOH): (a) Department of Health document prepared for the Office of Management and Budget, Department of the Treasury, State of New Jersey: Plan for Early Intervention Services for HIV-Infected Persons, June 1989; (b) Department of Health letter to Donald S. Goldman, member of the National Commission on AIDS, reporting on initial implementation and preliminary costs of the state early intervention plan, prepared by Christine Grant, J.D., M.B.A., Deputy Commissioner of Health, January 18, 1990. The New Jersey Department of Health specifies services and provides cost estimates for each of the four treatment categories, which are summarized in Table C-2. The source for the department's estimates is Jersey City Medical Center reported costs for the first three months (October-December 1989) of the New Jersey early intervention (TAP) program.

  2. AIDS Service, The Johns Hopkins School of Medicine and The Johns Hopkins Hospital (Baltimore, Md.); information provided by Mark D. Smith, M.D., Associate Director, AIDS Service, August 1990. The Johns Hopkins cost estimates are for services provided in accordance with National Institute of Allergy and Infectious Diseases treatment recommendations, which are summarized in Table C-2. The source of the AIDS Service cost estimates is per-item charges applied to the treatment protocol. The amount of actual reimbursement received by health services providers depends on the payer; Medicaid, Blue Cross, and commercial insurers each pay varying proportions of these charges.

Note: All estimates include the cost of pharmaceuticals when indicated for that treatment category, pharmaceuticals represent the predominant cost factor in treatment categories 2, 3, and 4.

Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×

TABLE C-2 Cost Estimates Per Intervention: Medical Surveillance, Prophylaxis, and Treatment

Source for Cost Estimate

Annual Servicesa

Annual Coat

Treatment Category 1: CD4+ Cells > 500

(1) Arno et al.

4 physician visits, 4 CD4 panels, 4 counseling visits

$ 854

(2) NJ DOH

Physician visits: initial, 1-2 wk. follow-up, then every 4 mos.; x-ray and lab includes VDRL, PPD, CBC with differential, platelets, CD4, HBsAg/Ab, gonococcal culture, Pap smear, chlamydia; case mgmt., nutrition, assess., educ./counseling each visit (visits every 4-8 wks. if CD4 count drops)

1,676

(3) Johns Hopkins

Physician visits: initial, 1-2 wk. follow-up, then every 3-6 mos. with CD4; initial lab includes CBC with differential, CD4, HBsAg/Ab, RPR, PPD, influenza, pneumococcal, hepatitis B virus vaccine

775

Treatment Category 2: CD4+ Cells 200 - 500, with Zidovudine

(1) Arno et al.

6-12 physician visits; 6-12 counseling visits; 6-12 CD4 panels

9,637b

(2) NJ DOH

As for Category 1, plus: physician visits every 2 wks. for 3 mos., then every 1-2 mos.; zidovudine; lab includes CBC with differential, hematocrit, CD4, platelets every visit

6,146

(3) Johns Hopkins

As for Category 1, plus: physician visits every month for 3 mos., then every 3 mos. with CBC with differential, CD4; zidovudine

3,620

Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×

Source for Cost Estimate

Annual Servicesa

Annual Cost

Treatment Category 3: CD4+ Cells < 200, with Zidovudine + trimethoprim-sulfamethoxazole (TMP-SMX)

(1) Arno et al.

6-12 physician visits; 6-12 counseling visits; 6-12 CD4 panels

9,637b

(2) NJ DOH

As for Category 2, plus: physician visits every 2 wks. for 2 mos., then every 1-2 mos.; TMP-SMX; lab includes creatinine

6,097

(3) Johns Hopkins

As for Category 2, plus: physician visits every 2-3 mos. with CBC, SMA-12; TMP-SMX

3,736

Treatment Category 4: CD4+ Cells < 200, with zidovudine + aerosolized pentamidine

(1) Arno et al.

6-12 physician visits; 6-12 counseling visits; 6-12 CD4 panels

9,637b

(2) NJ DOH

As for Category 2, plus: physician visits every 3 mos.; pentamidine every month; CD4 tests every 6 mos.

7,304

(3) Johns Hopkins

As for Category 2, plus: physician visits every 2-3 mos. with CBC, SMA-12; pentamidine every month

6,532

a VDRL, a serologic test for syphilis; PPD, purified protein derivative, a skin test for tuberculosis; CBC, complete blood count; HBsAg, hepatitis B surface antigen; HBAb, hepatitis B antibody; RPR, a serologic test for syphilis; SMA-12, 12 blood chemistry tests.

b This figure also includes costs of zidovudine therapy and primary PCP prophylaxis with aerosolized pentamidine or trimethoprim-sulfamethoxazole.

Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×

Part 2: Program Cost Estimates

TABLE C-3a Program Cost Estimates per 1,000 Infected Persons Detected: Counseling and Testing (using CDC cost estimates)

Cost per 1,000 HIV (+) Persons Detected

Counseling and testing for HIV (+) individuals (1,000 x $115)

$115,000

Partner notification for 1 contact per HIV (+) index case (1,000 x $43)

43,000

Counseling and testing for HIV (-) individualsa (7,333 x $43)

315,319

Total

473,319

TABLE C-3b Program Cost Estimates for One State: Counseling and Testing (using CDC cost estimate)

Cost in One State: New Jerseyb

Counseling and testing for all HIV (+) individuals (70,000 x $115)

$ 8,050,000

Partner notification for 1 contact per HIV (+) index case (70,000 x $43)

3,010,000

Counseling and testing for HIV (-) individualsa (513,300 x $43)

22,071,900

Total

33,031,900

a The ratio of HIV (-) individuals tested to HIV (+) individuals varies greatly by background infection rates, intensity of outreach and testing efforts, and other factors. As a greater proportion of HIV (+) individuals in one area are identified, the number of HIV (-) tests required to find each HIV (+) individual will increase. In New Jersey in 1988-1989, that ratio in publicly funded testing programs was 100:12. Using this ratio, a total of 8,333 individuals would have to be tested to identify 1,000 HIV (+) individuals, yielding 7,333 HIV (-) individuals.

b population of the state = 7.8 million; estimated number of HIV-infected individuals = 70,000.

Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×

TABLE C-4a Program Cost Estimates: Annual Costs per 1,000 HIV (+) Patients by Treatment Category (using New Jersey Department of Health and Johns Hopkins cost estimates) for Medical Surveillance, Prophylaxis, and Treatment

 

 

New Jersey Dept. of Health

Johns Hopkins

Treatment Categorya

Number of Patients/1,000 Patientsb

Annual Cost/patient

Total

Annual Cost/Patient

Total

1

500

$1,6%

$ 838,000

$ 775

$ 387,500

2

300

6,146

1,843,800

3,620

1,086,000

3

150

6,097

914,550

3,736

560,400

4

50

7,304

365,200

6,532

326,600

Total (1,000)

 

 

3,961,550

 

2,360,500

a Treatment categories: 1, CD4+ cells >500-medical monitoring; 2, CD4+ cells 200-500-treatment with zidovudine; 3, CD4+ cells < 200-treatment with zidovudine, prophylaxis with trimethoprim-sulfamethoxazole; 4, CD4+ cells < 200-treatment with zidovudine, prophylaxis with aerosolized pentamidine.

b Distribution of HIV (+) individuals among treatment categories. This proportion is derived from the New Jersey data but is consistent with the Johns Hopkins AIDS Service experience for all adult patients. HIV (+) women may be disproportionately represented in the earlier treatment categories.

TABLE C-4b Program Cost Estimates: Annual Costs for All HIV (+) Individuals in New Jersey (using New Jersey Department of Health and Johns Hopkins cost estimates) for Medical Surveillance, Prophylaxis, and Treatment

 

 

New Jersey Dept. of Health

Johns Hopkins

Treatment Category

Total Patients

Annual Cost/Patient

Total (in millions)

Annual Cost/Patient

Total (in millions)

1

35,000

$1,676

$ 58,660

$ 775

$ 27,125

2

21,000

6,146

129,066

3,620

76,020

3

10,500

6,097

64,019

3,736

39,228

4

3,500

7,304

25,564

6,532

22,862

Total

70,000

 

277,309

 

165,235

Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×
Page 135
Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×
Page 136
Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×
Page 137
Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×
Page 138
Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×
Page 139
Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×
Page 140
Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×
Page 141
Suggested Citation:"Appendix C: Cost Estimates: Early Intervention for HIV Infection." Institute of Medicine. 1991. HIV Screening of Pregnant Women and Newborns. Washington, DC: The National Academies Press. doi: 10.17226/1746.
×
Page 142
Next: Appendix D: Committee Biographical Notes »
HIV Screening of Pregnant Women and Newborns Get This Book
×
Buy Paperback | $50.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Proposals for screening pregnant women and newborns for HIV infection have provoked much controversy. This volume analyzes the possible goals of such screening programs and assesses whether these goals can currently be achieved. It also provides guidance to policymakers in developing and implementing sound screening policy.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!